Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2012-01-17 | Reverse | 1:10 |
Mannatech, Inc. is a global health and wellness company founded in 1993, selling nutritional supplements, skincare, anti-aging, and weight-management products through direct, e-commerce, and network marketing channels.

Mannatech's new science-backed 21-day program supports liver detox and overall wellness, marketed with incentives for new customers and associates.
In March 2025, reports emerged that Mannatech was under investigation by the Texas Attorney General's office for possible deceptive trade practices and making unapproved health claims about its products, including suggestions they could cure serious ailments. This event cast significant doubt on the company's marketing practices and the scientific basis of its products, creating substantial legal and reputational risk.
In response to declining sales and increasing losses throughout 2025, Mannatech's leadership made the strategic decision to extend the maturity date of $2.9 million in outstanding promissory notes. This move, executed with three related parties including board members, pushes the debt obligation to March 2027, providing the company with crucial time and working capital to navigate its challenging financial situation.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
MWYN | $1.59 | COMPARE |
EDTK | $0.93 | COMPARE |
AACG | $0.76 | COMPARE |
BTCT | $1.10 | COMPARE |
WVVI | $1.86 | COMPARE |
NAII | $1.32 | COMPARE |